The incidence of inhibitors in hemophilia A and the induction of immune tolerance.
Briët
E
E
Department of internal medicine and pediatrics, Academic medical center, Amsterdam, The Netherlands.
Peters
M
M
D015331:Cohort Studies; D003888:Desensitization, Immunologic / Q000191:economics; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D005169:Factor VIII / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006467:Hemophilia A / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D015994:Incidence; D007518:Isoantibodies / Q000276:immunology*; D009154:Mutation; D012306:Risk
D000939:Epitopes; D007518:Isoantibodies; D005169:Factor VIII